OssDsign AB (publ) (STO:OSSD)
4.045
+0.055 (1.38%)
May 5, 2026, 11:34 AM CET
OssDsign AB Revenue
In the year 2025, OssDsign AB had annual revenue of 180.16M SEK with 34.51% growth. OssDsign AB had revenue of 45.12M in the quarter ending December 31, 2025, with 8.87% growth.
Revenue
180.16M
Revenue Growth
+34.51%
P/S Ratio
2.45
Revenue / Employee
5.30M
Employees
34
Market Cap
441.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.16M | 46.22M | 34.51% |
| Dec 31, 2024 | 133.94M | 21.78M | 19.42% |
| Dec 31, 2023 | 112.16M | 55.18M | 96.84% |
| Dec 31, 2022 | 56.98M | 25.25M | 79.60% |
| Dec 31, 2021 | 31.73M | 6.85M | 27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| C-Rad AB | 441.90M |
| Mentice AB | 279.09M |
| Bactiguard Holding AB | 201.18M |
| Senzime AB | 103.76M |
| Ortoma AB | 67.27M |
| Promimic AB | 51.06M |
| BrainCool AB | 44.62M |
| SciBase Holding AB | 40.46M |
OssDsign AB News
- 3 months ago - OssDsign AB Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - OssDsign AB Transcript: ABGSC Investor Days - Transcripts
- 6 months ago - OssDsign AB Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - OssDsign AB Earnings Call Transcript: Q2 2025 - Transcripts
- 11 months ago - OssDsign AB Transcript: Study Update - Transcripts
- 11 months ago - OssDsign AB Transcript: Strategy Update - Transcripts
- 1 year ago - OssDsign AB Transcript: ABGSC Investor Days - Transcripts
- 1 year ago - OssDsign AB Earnings Call Transcript: Q1 2025 - Transcripts